Drugs.com - Clinical Trials

IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Tokyo and Basking Ridge, NJ – May 19, 2025 – The first patient has been dosed in the IDeateEsophageal01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab deruxtecan (I-DXd) versus investigator’s choice...

May 20, 2025 - 01:30
 0
IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Tokyo and Basking Ridge, NJ – May 19, 2025 – The first patient has been dosed in the IDeateEsophageal01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab deruxtecan (I-DXd) versus investigator’s choice...
Read More

Tags:

Previous Article

Global Phase III Trials Demonstrate That Nerandomilast Slowed Lung Function Decl...

Next Article

Infant with Carbamoyl Phosphate Synthetase 1 (CPS1) Deficiency First to Successf...

Related Posts

Apnimed Announces Positive Topline Results in the First Landmark Phase 3 Clinical Trial of AD109, an Investigational Once-Daily Oral Pill for Obstructive Sleep Apnea

Apnimed Announces Positive Topline Results in the First...

May 20, 2025  0

The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1

The New England Journal of Medicine Publishes Data from...

May 15, 2025  0

NIH Study Reveals How Inflammation Makes Touch Painful

NIH Study Reveals How Inflammation Makes Touch Painful

May 12, 2025  0